Acute Myeloid Leukemia
Showing NaN - NaN of 58
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
-
Los Angeles, California
- +9 more
Jun 27, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Orca-T
- Standard-of-Care
-
Duarte, California
- +13 more
Jan 25, 2023
Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)
Active, not recruiting
- Acute Myeloid Leukemia
- CPX-351
- +3 more
-
Duarte, California
- +9 more
Jan 3, 2023
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine (ASTX727)
- Venetoclax
-
Los Angeles, California
- +15 more
Jul 29, 2022
Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- AML, Adult
- evorpacept
- +2 more
-
Chicago, Illinois
- +4 more
Jun 7, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +13 more
-
Birmingham, Alabama
- +187 more
Apr 28, 2022
Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Uproleselan
- Placebo
-
La Jolla, California
- +69 more
Apr 5, 2022
Acute Myeloid Leukemia Trial in United States (Sapacitabine, Arm A, Sapacitabine, Arm B, Sapacitabine, Arm C)
Completed
- Acute Myeloid Leukemia
- Sapacitabine, Arm A
- +8 more
-
Birmingham, Alabama
- +14 more
Mar 23, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)
Enrolling by invitation
- Acute Lymphoblastic Leukemia
- +2 more
- CliniMacs TCR alpha-beta-Biotin system
-
Los Angeles, California
- +9 more
Feb 10, 2022
Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)
Terminated
- Acute Myeloid Leukemia
- Myeloid Dysplastic Syndrome
-
Buffalo, New York
- +20 more
Jan 21, 2022